Dr. Marie-Joëlle Mozziconacci - CML - Chronic myeloid leukemia
Institut Paoli-Calmettes,
Laboratory for molecular biology and cytogenetics
Marseille, France
Laboratory for molecular biology and cytogenetics
Marseille, France
VIDEOS IN FRENCH
Biologie de la LMC - Docteur Marie Joelle Mozziconacci
January 16, 2016, 2012, LMC FRANCE
PCR et LMC
April 14, 2015, 2012, LMC FRANCE
Historique de la Leucémie Myéloïde Chronique
September 24, 2012, LMC FRANCE
La biologie Moléculaire et la LMC
September 22, 2012, LMC FRANCE
Leucémie Myéloïde Chronique : prélèvement de moelle, biologie moléculaire et LMC September 22, 2012, LMC FRANCE
Biologie de la LMC - Docteur Marie Joelle Mozziconacci
January 16, 2016, 2012, LMC FRANCE
PCR et LMC
April 14, 2015, 2012, LMC FRANCE
Historique de la Leucémie Myéloïde Chronique
September 24, 2012, LMC FRANCE
La biologie Moléculaire et la LMC
September 22, 2012, LMC FRANCE
Leucémie Myéloïde Chronique : prélèvement de moelle, biologie moléculaire et LMC September 22, 2012, LMC FRANCE
ARTICLES
Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine
November 16, 2012, Blood
Myeloid malignancies: mutations, models and management
July 2012, BMC Cancer
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
Mar 2012, Journal of Hematology & Oncology
Impact of the Normalized Copy Number of BCR-ABL Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate
December 2011, Open Journal of Blood Diseases
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
November 2010, PublMed.
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
August 2010, BMC Cancer
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
June 2009, PublMed
Minor breakpoint cluster region (m-BCR) positive chronic myeloid leukaemia with an acute lymphoblastic leukaemia onset: a case report
March 12, 2008, British Journal of Hematology
Chromosome 19 abnormalities are commonly seen in AML, M7
November 15, 2002, Journal Blood
Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia
May 15, 2002, Journal Blood
Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine
November 16, 2012, Blood
Myeloid malignancies: mutations, models and management
July 2012, BMC Cancer
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
Mar 2012, Journal of Hematology & Oncology
Impact of the Normalized Copy Number of BCR-ABL Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate
December 2011, Open Journal of Blood Diseases
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
November 2010, PublMed.
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
August 2010, BMC Cancer
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
June 2009, PublMed
Minor breakpoint cluster region (m-BCR) positive chronic myeloid leukaemia with an acute lymphoblastic leukaemia onset: a case report
March 12, 2008, British Journal of Hematology
Chromosome 19 abnormalities are commonly seen in AML, M7
November 15, 2002, Journal Blood
Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia
May 15, 2002, Journal Blood
